Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
cisatracurium 2 mg/ml injektionsvæske, opløsning, ampul a 2,5 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
cisatracurium 5 mg/ml injektionsvæske, opløsning, ampul a 30 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
cisatracurium 2 mg/ml injektionsvæske, opløsning, ampul a 5 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
edrophoniumchlorid 10 mg/1 ml injektionsvæske |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
neostigmin 2,5 mg glycopyrronium 500 µg injektionsvæske, opløsning, ampul a 1 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
naloxonhydrochlorid 400 µg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 1 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
naloxonhydrochlorid 400 µg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 2 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
naloxonhydrochlorid 400 µg/ml injektionsvæske, opløsning, ampul a 1 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
naloxonhydrochlorid 20 µg/ml injektionsvæske, opløsning, ampul a 2 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Dantrolene sodium 20 mg powder for solution for injection vial |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
bupivacain 3,75 mg/ml (0,375 %) injektionsvæske, opløsning, steril ampul a 10 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
bupivacain 0,5 % + glucose injektionsvæske, opløsning, ampul a 4 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
prilocainhydrochlorid 4 % dental type, cylinderampul |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
ropivacainhydrochlorid 2 mg/ml injektionsvæske, opløsning, ampul a 10 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
ropivacainhydrochlorid 7,5 mg/ml injektionsvæske, ampul a 10 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
ropivacainhydrochlorid 10 mg/ml injektionsvæske, opløsning, ampul a 10 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
ropivacainhydrochlorid 2 mg/ml infusionsvæske, opløsning, pose a 100 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
ropivacainhydrochlorid 2 mg/ml infusionsvæske, opløsning, pose a 200 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
levobupivacain 7,5 mg/ml injektionsvæske, opløsning, ampul a 10 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
levobupivacain 5 mg/ml injektionsvæske, opløsning, ampul a 10 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
levobupivacain 2,5 mg/ml injektionsvæske, opløsning, ampul a 10 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
lidocainhydrochlorid 100 mg/10 ml (1 %) i fyldt injektionssprøjte |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
lidocainhydrochlorid 2 % til dental anvendelse, cylinderampul |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
lidocainhydrochlorid 100 mg/5 ml (2 %) i fyldt injektionssprøjte |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
lidocainhydrochlorid + adrenalin 0,5 %/1:200.000 injektionsvæske |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
fenoldopam 10 mg/ml injektionsvæske, opløsning, 1 ml ampul |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
fenoldopam 10 mg/ml injektionsvæske, opløsning, 2 ml ampul |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
tørret koppevaccine, kalvelymfe, 1 hætteglas + solvens 0,25 ml sprøjte |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
palonosetron 9,25 mg/5 ml injektionsvæske, opløsning, hætteglas a 5 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
tositumomab 14 mg/ml/jod-131 5,6 mCi/ml/tositumomab 1,1 mg/ml injektionsvæske, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
grenede aminosyrer, 4 % injektionsvæske |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Product containing precisely pemetrexed (as pemetrexed disodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Pegvisomant 20 mg powder for solution for injection vial |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
daptomycin 250 mg injektionsvæske, opløsning, hætteglas a 10 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
daptomycin 500 mg injektionsvæske, opløsning, hætteglas a 10 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Urokinase 5000 unit/mL solution for injection |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
dacarbazin 500 mg pulver til injektionsvæske, hætteglas, hætteglas a 50 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
glucose 10 % opløsning |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
glucose 20 % opløsning |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
glucose 30 % opløsning |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
glucose 40 % opløsning |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Glucose 500 mg/mL oral solution |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
glucose 60 % opløsning |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
glucose 70 % opløsning |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Product containing precisely daunorubicin (as daunorubicin hydrochloride) 5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
lidocain 1 %/bupivacain 0,375 % injektionsvæske, opløsning, 10 ml hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
atropin/pralidoxim injektionsvæske, opløsning, to autoinjektorer |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
atropin + pralidoxim, opløsning, enkelt autoinjektor |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
atropin 2,1 mg + pralidoxim 600 mg, opløsning, enkelt autoinjektor |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
atropin 2 mg + pralidoxim 600 mg opløsning, to autoinjektorer |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Adalimunab 40mg/mL injection solution 1mL prefilled syringe |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
acetylcystein 20 % injektionsvæske, opløsning, hætteglas a 30 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
arsentrioxid 1 mg/ml injektionsvæske, ampul a 10 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
rekombinant antihæmofilifaktormiddel 1000 IE injektionsvæske, opløsning, hætteglas a 1 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
rekombinant antihæmofilifaktormiddel 1500 IE injektionsvæske, opløsning, hætteglas a 1 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
rekombinant antihæmofilifaktormiddel 250 IE injektionsvæske, opløsning, hætteglas a 1 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
rekombinant antihæmofilifaktormiddel 500 IE injektionsvæske, opløsning, hætteglas a 1 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
laronidase 2,9 mg/5 ml injektionsvæske, opløsning, hætteglas a 5 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
galliumnitrat 500 mg/20 ml injektionsvæske, opløsning, hætteglas a 20 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
omalizumab 150 mg pulver til injektionsvæske, hætteglas a 5 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
busulfan 60 mg/10 ml injektionsvæske, ampul a 10 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
perflutren 2 ml, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
peginterferon alfa-2a 180 µg/ml injektionsvæske, hætteglas a 1 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
dihydrostreptomycinsulfat 200 mg pulver til injektionsvæske, ampul |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Product containing precisely secretin 16 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Manganklorid 0,1 mg/ml injektionsvæske, hætteglas a 10 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
somatropin 4 mg pulver til injektionsvæske, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
somatropin 8,8 mg pulver til injektionsvæske, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Product containing precisely hyaluronic acid 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
frusemid 10 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 4 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
furosemid 10 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 10 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
ziprasidonmesylat 20 mg/ml injektionsvæske, opløsning |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
doxercalciferol 2 µg/ml injektionsvæske, opløsning, ampul a 1 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
perflexan 200 mg lipidmikrosfærer injektionsvæske, suspension, hætteglas a 10 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
sincalid 5 µg pulver til injektionsvæske, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
cetuximab 2 mg/ml injektionsvæske, opløsning, hætteglas a 50 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
bevacizumab 25 mg/ml injektionsvæske, opløsning, hætteglas a 4 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
bevacizumab 25 mg/ml injektionsvæske, opløsning, hætteglas a 16 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Intravenøs fedtemulsion |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Intravenøs fedtemulsion 10 % opløsning |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Intravenøs fedtemulsion 20 % opløsning |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Intravenøs fedtemulsion 30 % opløsning |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
methotrexat 25 mg/ml injektionsvæske, opløsning, hætteglas a 10 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
laksecalcitonin 50 enheder/ml injektionsvæske, opløsning, hætteglas a 1 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
laksecalcitonin 100 enheder/ml injektionsvæske, opløsning, hætteglas a 1 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
nesiritid 1,5 mg pulver til injektionsvæske, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
tiotixenhydrochlorid 5 mg pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
somatropin 13,5 mg/3 ml injektionsvæske, opløsning, hætteglas a 3 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
somatropin 18 mg/3 ml injektionsvæske, opløsning, hætteglas a 3 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
somatropin 22,5 mg/3 ml injektionsvæske, opløsning, hætteglas a 3 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
gadoversetamid 0,5 mmol/ml injektionsvæske, opløsning |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
perflutren proteintype A-mikrosfærer, injektionsvæske, hætteglas a 3 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
ioxilan 300 mgI/ml injektionsvæske, opløsning |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
ioxilan 350 mgI/ml injektionsvæske, opløsning |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
carboplatin 10 mg/ml infusionsvæske, opløsning, hætteglas a 60 ml |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
natriumthiosulfat 12,5 g/50 ml injektionsvæske |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
Benzocaine compound injection solution BPC vial |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
infusionsvæske indeholdende flere elektrolytter |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
bupivacain 0,105 % infusionsvæske, opløsning, ampul |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
kardioplegisk koncentrat til infusionsvæske, hætteglas |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|
co-trimoxazol 960 mg/10 ml infusionsvæske til intravenøs anvendelse |
Has manufactured dose form |
False |
injektionsvæske |
Inferred relationship |
Some |
|